Dr Scott Turner
Abstract:In a system to detect an analyte concentration eg.blood sugar level, the body part 6 is illuminated by multiple wavelength illumination. The transmitted or reflected intensity at three discrete wavelengths are analysed by a computer. The wavelength at which the transmissivity of blood is unaffected by the analyte is denoted A and acts as a reference. At wavelengths B and C the transmissivity of the blood is respectively increased and decreased by the analyte, and the output signal, So, is generated from the relation The device incorporates a white light source 2 and a plurality of photodiodes 8 to monitor light at each predetermined wavelength or alternatively a plurality of light sources generate the predetermined wavelengths and a single photodiode receives the light. Patents Granted (not renewed)
1. Dobson PJ, Turner SJ (2001) Optical Glucose Detector Patent No. GB2328279 (B) UK. 10 October 2001. Patent number GB2328279 (B)
2. Dobson PJ, Turner SJ (2002) Optical Glucose Detector Patent No US6466807 (B1) USA. 15 October 2002. Patent number US6466807 (B1)
Related Applications
1. Dobson PJ, Turner SJ (1999) Three wavelength in-
2. Dobson PJ, Turner SJ (1999) Optical Glucose Detector, World Intellectual Property Organization, 18th February 1999, Patent Application WO9907278 (A1)
3. Dobson PJ, Turner SJ (1999) Optical Glucose Detector, Canada, 18th February 1999, Patent Application CA2299727 (A1)
4. Dobson PJ, Turner SJ (1999) Optical Glucose Detector, Australia, 1st March 1999, Patent Application AU8639198 (A)
5. Dobson PJ, Turner SJ (2000) Optical Glucose Detector, European Patent Office, 28th June 2000, Patent Application EP1011428 (A1)
6. Dobson PJ, Turner SJ (2001) Three wavelength in-
All views and opinions are the author's and do not necessarily reflected those of any organisation they are associated with. Twitter: @scottturneruon
No comments:
Post a Comment